Clinical Trials in Maryland

Showing 4021-4040 of 15,138 trials

Genes and Environment in Multiple Sclerosis

NCT01353547

The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.

Multiple Sclerosis

Columbia University5,000 participantsStarted Oct 2017

Bethesda, Maryland, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 317 miles

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

NCT02388906

The purpose of this study is to determine whether nivolumab is better than ipilimumab to prevent recurrence of melanoma.

Melanoma

Bristol-Myers Squibb906 participantsStarted Mar 2015

Little Rock, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +133 more locations

Genes and Environment in Multiple Sclerosis

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Find Trials by Condition in Maryland

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Prophylaxis and Treatment of COVID-19

DALY II USA/ MB-CART2019.1 for DLBCL

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency

Study of REM-422 in Patients With AML or Higher Risk MDS

Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA